231 related articles for article (PubMed ID: 25209393)
1. BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.
Wan S; Liu Y; Weng Y; Wang W; Ren W; Fei C; Chen Y; Zhang Z; Wang T; Wang J; Jiang Y; Zhou L; He T; Zhang Y
Cell Oncol (Dordr); 2014 Oct; 37(5):363-75. PubMed ID: 25209393
[TBL] [Abstract][Full Text] [Related]
2. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.
Wang K; Feng H; Ren W; Sun X; Luo J; Tang M; Zhou L; Weng Y; He TC; Zhang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1687-96. PubMed ID: 21892652
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes.
Wang T; Zhang Z; Wang K; Wang J; Jiang Y; Xia J; Gou L; Liu M; Zhou L; He T; Zhang Y
Oncotarget; 2017 May; 8(22):35890-35901. PubMed ID: 28415788
[TBL] [Abstract][Full Text] [Related]
4. Inhibin α-subunit inhibits BMP9-induced osteogenic differentiation through blocking BMP/Smad signal and activating NF-κB signal in mesenchymal stem cells.
Huang M; Cheng YL; Zeng JT; Su XY; Liu H
J Cell Biochem; 2018 Nov; 119(10):8271-8281. PubMed ID: 29923343
[TBL] [Abstract][Full Text] [Related]
5. BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell‑derived microenvironment through the MAPK/ERK and NF-κB pathways.
Wang J; Weng Y; Zhang M; Li Y; Fan M; Guo Y; Sun Y; Li W; Shi Q
Oncol Rep; 2016 Jul; 36(1):410-8. PubMed ID: 27177272
[TBL] [Abstract][Full Text] [Related]
6. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.
Ren W; Sun X; Wang K; Feng H; Liu Y; Fei C; Wan S; Wang W; Luo J; Shi Q; Tang M; Zuo G; Weng Y; He T; Zhang Y
Mol Biol Rep; 2014 Mar; 41(3):1373-83. PubMed ID: 24413988
[TBL] [Abstract][Full Text] [Related]
7. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.
Choi S; Yu J; Kim W; Park KS
Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853
[No Abstract] [Full Text] [Related]
8. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
9. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.
Ren W; Liu Y; Wan S; Fei C; Wang W; Chen Y; Zhang Z; Wang T; Wang J; Zhou L; Weng Y; He T; Zhang Y
PLoS One; 2014; 9(5):e96816. PubMed ID: 24805814
[TBL] [Abstract][Full Text] [Related]
10. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
12. Biological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cells.
Wang W; Weng Y; Ren W; Zhang Z; Wang T; Wang J; Jiang Y; Chen Y; Zhou L; He T; Zhang Y
Am J Transl Res; 2015; 7(9):1660-74. PubMed ID: 26550465
[TBL] [Abstract][Full Text] [Related]
13. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases.
Arrigoni C; De Luca P; Gilardi M; Previdi S; Broggini M; Moretti M
Mol Cancer; 2014 Oct; 13():238. PubMed ID: 25335447
[TBL] [Abstract][Full Text] [Related]
14. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
Zhao Y; Song T; Wang W; Wang J; He J; Wu N; Tang M; He B; Luo J
PLoS One; 2012; 7(8):e43383. PubMed ID: 22912865
[TBL] [Abstract][Full Text] [Related]
15. BMP9 inhibits the growth of breast cancer cells by downregulation of the PI3K/Akt signaling pathway.
Li S; Dai H; He Y; Peng S; Zhu T; Wu Y; Li C; Wang K
Oncol Rep; 2018 Sep; 40(3):1743-1751. PubMed ID: 30015950
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 9 enhances osteogenic and angiogenic responses of human amniotic mesenchymal stem cells cocultured with umbilical vein endothelial cells through the PI3K/AKT/m-TOR signaling pathway.
Liu Z; Li Y; Yang J; Huang J; Luo C; Zhang J; Yan W; Ao Y
Aging (Albany NY); 2021 Nov; 13(22):24829-24849. PubMed ID: 34837694
[TBL] [Abstract][Full Text] [Related]
17. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells.
Liu X; Qin J; Luo Q; Bi Y; Zhu G; Jiang W; Kim SH; Li M; Su Y; Nan G; Cui J; Zhang W; Li R; Chen X; Kong Y; Zhang J; Wang J; Rogers MR; Zhang H; Shui W; Zhao C; Wang N; Liang X; Wu N; He Y; Luu HH; Haydon RC; Shi LL; Li T; He TC; Li M
J Cell Mol Med; 2013 Sep; 17(9):1160-72. PubMed ID: 23844832
[TBL] [Abstract][Full Text] [Related]
19. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
20. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells.
Hu N; Jiang D; Huang E; Liu X; Li R; Liang X; Kim SH; Chen X; Gao JL; Zhang H; Zhang W; Kong YH; Zhang J; Wang J; Shui W; Luo X; Liu B; Cui J; Rogers MR; Shen J; Zhao C; Wang N; Wu N; Luu HH; Haydon RC; He TC; Huang W
J Cell Sci; 2013 Jan; 126(Pt 2):532-41. PubMed ID: 23203800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
